vTv Therapeutics (VTVT) Amortization of Deferred Charges (2015)
vTv Therapeutics' (VTVT) quarterly Amortization of Deferred Charges came in at $13000.0 in Q2 2015, down 7.14% quarter-over-quarter from $14000.0 in Q1 2015.
vTv Therapeutics (VTVT) Amortization of Deferred Charges (2015) Analysis & Trends
vTv Therapeutics has disclosed Amortization of Deferred Charges across 1 years of filings, most recently posting $13000.0 for Q2 2015.
- Amortization of Deferred Charges for Q2 2015 came in at $13000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $27000.0 (changed N/A YoY), and the FY2015 annual result was $27000.0, down 81.38% from the prior year.
- Amortization of Deferred Charges came in at $13000.0 for Q2 2015 at vTv Therapeutics, down from $14000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $14000.0 in Q1 2015 to a low of $13000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 13,000.00 |
| Jun 30, 2015 | 13,000.00 |
| Mar 31, 2015 | 14,000.00 |
| Mar 31, 2015 | 14,000.00 |